Results 221 to 230 of about 47,940 (359)

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation

open access: yesChemMedChem, EarlyView.
Small molecules form a covalent bond at KRAS tyrosine and inhibit its activation by guanine exchange factors in biochemical assays and mammalian cells. The development of the KRAS G12C inhibitor sotorasib is a major advance toward drugging KRAS. However, the G12C mutation is only found in about 10% of KRAS‐driven tumors. KRAS possesses several tyrosine
Alexander D. Landgraf   +5 more
wiley   +1 more source

First Phosphonic‐Type Inhibitors and Activity‐Based Probes Specific to the O'nyong‐nyong Virus Capsid Protease

open access: yesChemMedChem, EarlyView.
The serine capsid protease (CP) catalyzes a crucial process of the alphaviral replication cycle; therefore, it constitutes an interesting therapy target. Herein, the O'nyong‐nyong virus CP profile activity with a specific fluorogenic substrate is analyzed and examines the inhibitory activity of a new series of phosphonic analogs of tryptophan and ...
Karolina Torzyk‐Jurowska   +5 more
wiley   +1 more source

FRACTIONATION AND CHARACTERIZATION OF CYSTEINE PROTEINASE INHIBITOR FROM CHICKEN PLASMA

open access: gold, 2005
Saroat Rawdkuen   +3 more
openalex   +1 more source

Inhibition of Endosomal Insulin-like Growth Factor-I Processing by Cysteine Proteinase Inhibitors Blocks Receptor-mediated Functions [PDF]

open access: hybrid, 2001
Roya Navab   +5 more
openalex   +1 more source

Innate Immunity in Insects: The Lights and Shadows of Phenoloxidase System Activation. [PDF]

open access: yesInt J Mol Sci
Zdybicka-Barabas A   +3 more
europepmc   +1 more source

Processing of mitochondrial precursor proteins [PDF]

open access: yes, 1991
Arretz, Michael   +3 more
core  

Deferasirox Derivatives as Inhibitors of Kallikrein‐Related Peptidases Associated to Neurodegenerative Diseases

open access: yesChemMedChem, EarlyView.
Dysregulated proteolysis mediated by kallikrein‐related peptidases (KLKs) and iron overload are involved in the progression of neurodegenerative diseases. Deferasirox, an clinically‐approved iron chelator, and its newly synthesized derivatives have been identified as inhibitors of major central nervous system KLKs with low cytotoxicity and effective ...
Rilès Boumali   +11 more
wiley   +1 more source

Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases [PDF]

open access: bronze, 2001
Yuan‐Ping Pang   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy